5α-Reductase Deficiency
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
5α-Reductase type 2 deficiency is an inherited condition in which the body makes too little dihydrotestosterone (DHT) from testosterone. In people with a 46,XY chromosome pattern, this can affect genital development before birth. External genitalia may be female-appearing, atypical, or male-appearing with a small penis or hypospadias. Testosterone can cause substantial physical changes at puberty. Fertility and treatment needs vary; care should reflect the person's anatomy, health and preferences.
Clinical Definition
5α-Reductase type 2 deficiency is an autosomal recessive SRD5A2-related 46,XY DSD caused by impaired conversion of testosterone to DHT. Reduced fetal DHT action affects external genital and prostate development; testosterone-dependent Wolffian structures are generally preserved, and Sertoli-cell AMH causes Müllerian regression. Pubertal testosterone can produce virilization despite persistent DHT deficiency. Phenotype ranges from isolated micropenis to female-appearing external genitalia.